Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
3M | MMM | Mar 28, 2025 | 144.84 | -2.43 |
4D Molecular Therapeutics | FDMT | Mar 28, 2025 | 3.63 | +1.97 |
51Talk Online Education Group ADR | COE | Mar 28, 2025 | 21.01 | +1.45 |
5E Advanced Materials | FEAM | Mar 28, 2025 | 4.10 | +1.22 |
60 Degrees Pharmaceuticals | SXTP | Mar 28, 2025 | 1.84 | +1.10 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Mar 28, 2025 | 13.68 | -2.22 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Mar 28, 2025 | 25.14 | +2.28 |
7-10 Yr Trsy Ishares | IEF | Mar 28, 2025 | 95.09 | +0.81 |
89bio | ETNB | Mar 28, 2025 | 8.08 | -9.82 |
8x8 | EGHT | Mar 28, 2025 | 1.99 | -5.69 |
908 Devices | MASS | Mar 28, 2025 | 4.04 | +0.75 |
9F ADR | JFU | Mar 28, 2025 | 1.41 | -6.00 |
A-Mark Precious Metals | AMRK | Mar 28, 2025 | 26.45 | -6.90 |
a.k.a Brands | AKA | Mar 28, 2025 | 14.29 | -0.97 |
A.O Smith | AOS | Mar 28, 2025 | 65.61 | -1.93 |
A10 Networks | ATEN | Mar 28, 2025 | 16.74 | -3.07 |
A2Z Cust2Mate Solutions | AZ | Mar 28, 2025 | 7.31 | -1.48 |
AA Mission Acquisition | AAM | Mar 28, 2025 | 10.28 | +0.10 |
AAA - A Rated Corporate Bond Ishares | QLTA | Mar 28, 2025 | 47.44 | +0.47 |
Aadi Bioscience | AADI | Mar 28, 2025 | 2.05 | 0.00 |
AAON | AAON | Mar 28, 2025 | 78.08 | -2.69 |
AAR | AIR | Mar 28, 2025 | 57.14 | -16.40 |
Aardvark Therapeutics | AARD | Mar 28, 2025 | 7.74 | 0.00 |
Abacus Global Management | ABL | Mar 28, 2025 | 7.62 | +6.57 |
Abbott Laboratories | ABT | Mar 28, 2025 | 130.82 | -0.40 |
AbbVie | ABBV | Mar 28, 2025 | 205.29 | +1.27 |
AbCellera Biologics | ABCL | Mar 28, 2025 | 2.31 | -2.12 |
Abeona Therapeutics | ABEO | Mar 28, 2025 | 4.97 | -1.39 |
Abercrombie & Fitch | ANF | Mar 28, 2025 | 76.57 | -1.24 |
Aberdeen Asia-Pacificome Fund | FAX | Mar 28, 2025 | 15.67 | +0.19 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.